Biostar Beta. Not for public use.
News: Bringing the power of Big Data to biomedical researchers
6
Entering edit mode

Very interesting article about NGS, downstream data analysis and benefits to biomedical research and healthcare, covering several start-up companies.

Please find the article on page 22 of this pdf

ADD COMMENTlink 2.5 years ago Paul Kutzner • 100 • updated 2.5 years ago Michael Dondrup 46k
Entering edit mode
0

This looks still suspicious, account is temporarily suspended because of suspicious voting pattern.

Protocol:

  • User posts first post, and receives 4 upvotes almost immediately
  • post deleted for looking suspicious/spam
  • User receives comment from senior moderator that links looks suspicious
  • Instead of responding to comment first, re-posts, receives 6 upvotes within seconds
  • user suspended
ADD REPLYlink 2.5 years ago
Michael Dondrup
46k
Entering edit mode
0

As a moderator you can not see who up-voted it and how much time it took to have 6 up-votes?

ADD REPLYlink 2.5 years ago
Medhat
8.3k
Entering edit mode
0

If i watch the post I can see the upvotes appear right after the post was posted.

ADD REPLYlink 2.5 years ago
Michael Dondrup
46k
Entering edit mode
0

No we can't see anything. Only "site admins" may.

ADD REPLYlink 2.5 years ago
genomax
68k
Entering edit mode
0

Actually, I directly up-voted the link today, since my company is part of the article and I recognized the title when it popped up in front of me.

I have one question: Since you directly closed the first post, can Paul see your comment and/or respond to it?

ADD REPLYlink 2.5 years ago
David Langenberger
8.9k
Entering edit mode
0

Hello Paul Kutzner!

We believe that this post does not fit the main topic of this site.

likely spam

For this reason we have closed your question. This allows us to keep the site focused on the topics that the community can help with.

If you disagree please tell us why in a reply below, we'll be happy to talk about it.

Cheers!

ADD REPLYlink 2.5 years ago
Michael Dondrup
46k
Entering edit mode
0

Did you just suspend his account and asked him afterwards to reply?

I got a link to this article on twitter some days ago and it does not look like spam. It's an overview about the usage of NGS in biomedical research. Besides Pine Biotech, there are several other companies named and no one is favoured. I actually just upvoted this post right before you closed it, since I liked reading it. But in the end it's your decision to close it.

I just wanted to add my two cents. :)

ADD REPLYlink 2.5 years ago
Lars
• 650
Entering edit mode
1

If the article contained information about several companies there was no need to single one out in the description that accompanied the article link.

ADD REPLYlink 2.5 years ago
genomax
68k
Entering edit mode
0

Good point, changed it a little.

ADD REPLYlink 2.5 years ago
Michael Dondrup
46k
Entering edit mode
0

Sorry if this was a legit post, however I left the user time to respond first because the flash link looked crappy.

Instead the post appeared again, without any further explanation. My policy is, if it looks like spam, it is possibly not worth keeping the post. The post fell short of convincing me that it was not spam, so I deleted it.

ADD REPLYlink 2.5 years ago
Michael Dondrup
46k
Entering edit mode
0

Hi Paul,

I have re-opened your post. Next time, please take your time to write something substantial in your own post so it does not look like spam.

ADD REPLYlink 2.5 years ago
Michael Dondrup
46k

Login before adding your answer.

Similar Posts
Loading Similar Posts
Powered by the version 2.0